Home | |
|
BETAFERON® is the tradename for interferon-beta-1b, a therapy that is indicated for certain patients with the relapsing-remitting and secondary progressive forms of MS. In the USA and Canada, the same drug has the tradename, BETASERON®. This section of the site aims to give you as much practical and background information about the drug as we are allowed to make available to the general public by the regulations governing the pharmaceutical industry. If you have questions about BETAFERON® which are not answered here, please consult your treating physician.
|
|||||||||||||||||||||||||||||
|
Fact file |
The information on this page was last updated/verified on:April 6, 2001 |
Home | Links | Registration and Feedback | Search Engine and Site map | Glossary | Local Information | About this site/Help | Tell a friend | Disclaimer | Press Information | Schering |